Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease

Citation
E. Engidawork et al., Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease, BIOC BIOP R, 281(1), 2001, pp. 84-93
Citations number
56
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
281
Issue
1
Year of publication
2001
Pages
84 - 93
Database
ISI
SICI code
0006-291X(20010216)281:1<84:AOCAAP>2.0.ZU;2-1
Abstract
Dysregulated programmed cell death or apoptosis Al Alzheimer's disease (AD) . Caspases, the major effects suggested to be involved in the pathogenesis of tors of apoptosis, are cysteine proteases that cleave crucial substrate proteins exclusively after aspartate residues. The activity of caspases are delicately regulated by a variety of proteins that possess distinct domain s for protein-protein interaction. To further substantiate the role of apop tosis in AD, we investigated the levels of nine different proteins involved in apoptosis by Western blot technique in frontal cortex and cerebellum of control and AD subjects. The protein levels of caspase-3, -8, and -9, DFF4 5 (DNA fragmentation factor 45), and FLIP (Fas associated death domain (FAD D)-like interleukin-1 beta -converting enzyme inhibitory proteins) were dec reased, whereas those of ARC (apoptosis repressor with caspase recruitment domain) and RICK (Receptor interacting protein (RIP)-like interacting CLARP kinase) increased in AD. In contrast;, cytochrome c and Apaf-1 (apoptosis protease activating factor-1) were unchanged. Regression analysis revealed no correlation between levels of protein and postmortem interval. However, inconsistent correlation was found between age and levels of proteins as we ll as among the levels of individual proteins. The current findings showed that dysregulation of apoptotic proteins indeed exists in AD brain and supp ort the notion that it may contribute to neuropathology of AD. The study fu rther hints that apoptosis in AD may occur via the death receptor pathway i ndependent of cytochrome c. Hence, therapeutic strategies that ablate caspa se activation may be of some benefit for AD sufferers. (C) 2001 Academic Pr ess.